|Alex Chang ZOU
Biomedical Sciences, Ph.D, The Chinese University of Hong Kong, China.
|Management experiences: 1. Acting leader 15 staffs) 4 months Simcere Pharmaceutical Co. Ltd. Nanjing, China, 2008.03-2008.07 2. Project manager, 7 member?s team, 3 projects Simcere Pharmaceutical Co. Ltd. Nanjing, China 2007.07-2009.07 3. Research Associate 2012.10-2014.01 School of Biomedical Sciences, The Chinese University of Hong Kong 4. Academic Director 2014.01-2014.11 Shen Zhen Hornetcorn Biological Co.?Ltd. 5. Senior Researcher in Clinical Research Centre, 2014.11-present The Second Clinical Medical College of Jinan University. Shenzhen, China Focused on cell therapy Project experiences? 1. Phage-displayed peptides targeting esophageal cancer screening and idenitfying South East University, Nan Jing, China. 2004.09-2007.07. 2. Dose-effect curve and development of new applications of Endostatin Simcere Pharmaceutical Co. Ltd. Nanjing, China 2007.07-2009.07 3. The development of rabbit anti-VEGF therapeutic monoclonal antibody Simcere Pharmaceutical Co. Ltd. Nanjing, China 2008.07-2009.07. 4. Functional study of an nuclear receptor ERR? in prostate cancer RGC in Hong Kong (No. 14100914) and a travel grant by France and Hong Kong The Chinese University of Hong Kong (CUHK) 2009.08-2014.01 Clinical experiences? Qualified physician and treated both emergency and in-hospital patients with surgical disorders as in Dong Rui Hospital, Nanjing, China, 2002-2004.|
|Cancer research, Genetics, Clinical medicine|
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub Last revised : February 17, 2018